Home › Studies › PRJNA1002850
PRJNA1002850 SRP453664

14-strain probiotic in healthy UK adults, single-arm trial

An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: A single arm open label trial.

82 fecal samples from healthy adults (n=41) in Manchester, United Kingdom, in a single-arm open-label trial assessing gut microbiome changes after 8 weeks of 14-strain probiotic supplementation. machine-written summary

82 samples · 82 runs · GB · Adult · 2024 · 13.76 Gbp / sample

Sources
✓Sequence archive 656○Abstract / description✓Full text 164○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive656 sample values (collection date, country, latitude, location locality, location region, longitude, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text164 sample values (health condition, health condition detail) · PMC10570534
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Probiotic (live microorganisms; single strain or mixture) design single_arm_before_after · population healthy_control · 14-strain probiotic blend, 8 billion CFU/day, 8 weeks, single arm

“consumed 4 capsules daily of the 14 strain blend” — abstract:37841999 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult82
Condition
healthy_control82
Country
GB82
Body site
primary82
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 82 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 13.76 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

41 of 41 people sampled more than once (82 samples; median 2, up to 2 per person) · follow-up median 56 d (max 56 d) · median interval between samples 56 d (time from visit codes mapped to the stated schedule). Schedule stated by the source: “Stool collected at baseline (Day 0) and end of study (Day 56 ± 2 days)” (time origin: intervention_start); stated follow-up 56 d.

1-011-01: day 01-01: day 561-021-02: day 01-02: day 561-031-03: day 01-03: day 561-041-04: day 01-04: day 561-051-05: day 01-05: day 561-071-07: day 01-07: day 561-081-08: day 01-08: day 561-091-09: day 01-09: day 561-101-10: day 01-10: day 561-111-11: day 01-11: day 561-121-12: day 01-12: day 561-141-14: day 01-14: day 561-151-15: day 01-15: day 561-161-16: day 01-16: day 561-171-17: day 01-17: day 561-181-18: day 01-18: day 561-201-20: day 01-20: day 561-211-21: day 01-21: day 561-221-22: day 01-22: day 561-231-23: day 01-23: day 561-241-24: day 01-24: day 561-251-25: day 01-25: day 561-261-26: day 01-26: day 561-271-27: day 01-27: day 561-281-28: day 01-28: day 561-291-29: day 01-29: day 561-301-30: day 01-30: day 561-311-31: day 01-31: day 561-331-33: day 01-33: day 561-341-34: day 01-34: day 561-351-35: day 01-35: day 561-361-36: day 01-36: day 561-371-37: day 01-37: day 562-012-01: day 02-01: day 562-032-03: day 02-03: day 562-042-04: day 02-04: day 560 d14 d28 d42 d56 d

Each row is one person (36 shown of 41); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Faecalibacterium 8.4%Bifidobacterium 7.4%Roseburia 7.1%Alistipes 5.9%Bacteroides 5.4%Phocaeicola 4.8%Blautia_A 4.5%Prevotella 3.1%Gemmiger 2.7%Fusicatenibacter 2.4%Ruminococcoides 2.1%Collinsella 2.0%not assigned to a genus 3.6%other genera 40.5%

Genera, mean relative abundance over 69 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category82 100%
country82 100%82
health_condition82 100%82
subject_id82 100%82
collection_date82 100%82
detailed_location82 100%
health_condition_detail82 100%82
latitude82 100%82
location_locality82 100%82
location_region82 100%82
longitude82 100%82
timepoint_label82 100%82
Papers (1)
  • An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial. 2023 PMID 37841999 PMC10570534 own_data
Details
Archive description

The present, single arm, open label clinical trial, evaluated compositional and functional changes in the gut microbiome of healthy adults after 14 strain probiotic supplementation by high-throughput molecular approaches.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “alterations in the gut microbiome of healthy”
  • body site study.description · “changes in the gut microbiome of healthy”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.title · “microbiome of healthy adults in response to”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN36864701collection_date2021-02-12R10.90biosample.attribute:collection_date2021-02-12
SAMN36864701countryGBR10.90sample.attr.geo_loc_nameUnited Kingdom: Manchester
SAMN36864701health_conditionhealthy_controlR30.60paper.fulltext.results41 healthy young adults were enrolled in this open-label study
SAMN36864701health_condition_detailhealthy adultsR30.60paper.fulltext.results41 healthy young adults were enrolled in this open-label study
SAMN36864701latitude53.4812R10.90biosample.attribute:lat_lon53.4812 N 2.2424 W
SAMN36864701location_localityManchesterR10.85biosample.attribute:geo_loc_nameUnited Kingdom: Manchester
SAMN36864701location_regionEnglandR10.60biosample.attribute:lat_lon53.4812 N 2.2424 W
SAMN36864701longitude-2.2424R10.90biosample.attribute:lat_lon53.4812 N 2.2424 W
SAMN36864701subject_id1-01R10.70sample.name_rule:TITLETITLE: Subject ID 1-01, Baseline
SAMN36864701timepoint_labelBaselineR10.70sample.name_rule:TITLETITLE: Subject ID 1-01, Baseline
Sequencing

82 runs over 82 samples · mean 13.57 Gbp per run (median 13.76 Gbp, total 1,112.37 Gbp; 82 runs with a base count) · layout PAIRED 82 · platform ILLUMINA 82 · models Illumina NovaSeq 6000 (82) · 84% of runs with a Sandpiper profile · first public 2024-12-29

Authors (10)

Rodenes-Gavidia A first · Lamelas A · Bloor S · Hobson A · Treadway S · Haworth J · Vijayakumar V · Naghibi M · Day R · Chenoll E last

Downloads

PRJNA1002850.csv.gz (3.0 KB) · parquet (73.9 KB) — all 82 samples, every field with route and confidence · PRJNA1002850_determinations.csv.gz (6.0 KB) — 820 evidence rows

Samples (82 · every field this project has values for · hover a cell for its source)
Loading the sample table…